This is a peptide that contains the amino acid sequence alanine at positions 1, 3, 11 and 15.
[Ala1,3,11,15]-Endothelin 1 is a synthetic peptide analogue of the naturally occurring vasoactive peptide endothelin-1, characterized by the substitution of alanine residues at positions 1, 3, 11, and 15. This structural modification imparts distinct biochemical properties, making it a valuable tool for scientific investigation in vascular biology, receptor pharmacology, and peptide-receptor interaction studies. The peptide exhibits altered binding affinities and functional activities compared to native endothelin-1, which enables researchers to dissect the roles of specific amino acid residues in receptor activation and signal transduction. Its stability and unique interaction profile make it especially suitable for in vitro experimentation, where precise modulation of endothelin pathways is required. [Ala1,3,11,15]-Endothelin 1 is frequently employed in the elucidation of endothelin receptor subtype selectivity and the downstream cellular responses mediated by these interactions, providing a versatile platform for advancing our understanding of peptide-mediated signaling mechanisms.
Vascular Biology Research: The modified endothelin-1 analogue serves as a critical probe in vascular biology research, allowing scientists to investigate the mechanisms underlying vasoconstriction and vasodilation. By selectively engaging with endothelin receptors on vascular smooth muscle cells and endothelial cells, [Ala1,3,11,15]-Endothelin 1 enables the dissection of receptor-mediated signaling cascades that regulate vascular tone. Its unique amino acid substitutions provide insights into the structure-activity relationships governing peptide-receptor interactions, facilitating the identification of key residues involved in receptor binding and activation. This knowledge is instrumental in mapping the molecular basis of vascular homeostasis and the pathological processes associated with dysregulated endothelin signaling.
Receptor Pharmacology Studies: In the context of receptor pharmacology, the peptide is widely utilized to characterize the functional properties of endothelin receptor subtypes, including ETA and ETB. Researchers employ [Ala1,3,11,15]-Endothelin 1 in binding assays and functional response experiments to delineate receptor selectivity and agonist efficacy. The altered affinities and potencies resulting from its alanine substitutions make it an ideal candidate for competitive binding studies and receptor mapping. These investigations contribute to a deeper understanding of ligand-receptor specificity and the molecular determinants of receptor activation, which are essential for the rational design of selective endothelin receptor modulators.
Peptide-Receptor Interaction Analysis: The study of peptide-receptor interactions benefits significantly from the use of this endothelin-1 variant. By comparing the biological activities of native and modified peptides, researchers can pinpoint the contributions of individual amino acid residues to receptor recognition and signal initiation. [Ala1,3,11,15]-Endothelin 1 is particularly useful in mutagenesis studies and molecular modeling, where its defined structure serves as a reference for assessing the impact of specific residue changes on receptor binding dynamics. These analyses yield valuable data for the development of novel peptide analogues with tailored pharmacological profiles.
Signal Transduction Pathway Elucidation: The ability of [Ala1,3,11,15]-Endothelin 1 to selectively activate or inhibit certain signaling pathways makes it an indispensable tool for elucidating the molecular mechanisms governing endothelin-mediated cellular responses. Researchers employ the peptide to probe intracellular signaling events such as calcium mobilization, phosphorylation cascades, and gene expression changes triggered by endothelin receptor engagement. This approach enables the dissection of complex signaling networks and the identification of downstream effectors involved in vascular and non-vascular endothelin functions.
Structure-Activity Relationship (SAR) Investigations: The systematic substitution of alanine residues in the peptide sequence provides a powerful strategy for studying structure-activity relationships within the endothelin family. [Ala1,3,11,15]-Endothelin 1 serves as a template for SAR analyses, allowing scientists to correlate specific structural modifications with changes in biological activity and receptor affinity. These studies inform the rational design of new peptide analogues with enhanced selectivity, potency, or stability, advancing the field of peptide-based research tools and therapeutic candidates. By leveraging its unique properties, researchers can expand the repertoire of molecular probes available for investigating peptide-receptor systems and their physiological roles.
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More